Filtros de búsqueda

Lista de obras de Gionata Fiorino

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management

artículo científico publicado en 2016

A Health Technology-Related Cost Description Concerning Italian Ibd Centres Dealing With Crohn's Disease Results From Sole Study

article

A Phase 2a, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of IBD98-M Delayed-Release Capsules to Induce Remission in Patients with Active and Mild to Moderate Ulcerative Colitis

scientific article published on 30 May 2019

A multicentre prospective cohort study assessing the effectiveness of budesonide MMX® (Cortiment®MMX®) for active, mild-to-moderate ulcerative colitis

artículo científico publicado en 2019

Acute severe colitis: infliximab and/or cyclosporine?

artículo científico publicado en 2011

Adalimumab and Azathioprine Combination Therapy for Crohn's Disease: A Shining Diamond?

artículo científico publicado en 2016

Adalimumab for the treatment of pediatric Crohn's disease

artículo científico

Adalimumab in ulcerative colitis: hypes and hopes

artículo científico publicado en 2011

Anemia in Inflammatory Bowel Disease: The Opening of Pandora's Box?

artículo científico publicado en 2015

Anti-TNF Biosimilars in Inflammatory Bowel Disease: Searching the Proper Patient's Profile

artículo científico publicado en 2019

Antigenic response to CT-P13 and infliximab originator in inflammatory bowel disease patients shows similar epitope recognition

artículo científico publicado en 2018

Biologic Therapies and Risk of Infection and Malignancy in Patients With Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis.

artículo científico publicado en 2016

Biologic therapies in ulcerative colitis: primi inter pares?

artículo científico publicado en 2016

Biological agents for moderately to severely active ulcerative colitis: a systematic review and network meta-analysis

artículo científico publicado en 2014

Biological therapy for ulcerative colitis: what is after anti-TNF.

scientific article published on September 2011

Biosimilar Drugs for Inflammatory Bowel Disease: Is Similar Good Enough?

scientific article published on 01 November 2017

Biosimilar therapies in inflammatory bowel disease: should we care about patient profile?

artículo científico publicado en 2016

Blockade of lymphocyte trafficking in inflammatory bowel diseases therapy: importance of specificity of endothelial target

artículo científico publicado en 2014

Bowel Damage as Assessed by the Lémann Index is Reversible on Anti-TNF Therapy for Crohn’s Disease

artículo científico publicado en 2015

Bowel damage assessment in Crohn's disease by magnetic resonance imaging

artículo científico publicado en 2012

Calcium supplementation for the prevention of colorectal adenomas: A systematic review and meta-analysis of randomized controlled trials

artículo científico publicado en 2016

Can IL-23 be a good target for ulcerative colitis?

artículo científico publicado en 2018

Capsule endoscopy in Crohn's disease

artículo científico publicado en 2012

Catching the therapeutic window of opportunity in early Crohn's disease.

artículo científico

Changes in Biosimilar Knowledge among European Crohn's Colitis Organization [ECCO] Members: An Updated Survey.

artículo científico publicado en 2016

Commentary: Adjunct antibiotic combination therapy for ulcerative colitis--is it time to investigate Fusobacterium varium?

artículo científico publicado en 2014

Commentary: anaemia in inflammatory bowel disease--the most common and ignored extra intestinal manifestation

artículo científico publicado en 2014

Commentary: antibodies reacting with the infliximab Fab portion--something new?

artículo científico publicado en 2013

Commentary: associations between immune activation, intestinal permeability and irritable bowel syndrome.

artículo científico publicado en 2013

Comparative Accuracy of Bowel Ultrasound Versus Magnetic Resonance Enterography in Combination With Colonoscopy in Assessing Crohn’s Disease and Guiding Clinical Decision-making

artículo científico publicado en 2018

Comparative safety of systemic and low-bioavailability steroids in inflammatory bowel disease: Systematic review and network meta-analysis.

artículo científico publicado en 2017

Comparison between 1.5 and 3.0 Tesla magnetic resonance enterography for the assessment of disease activity and complications in ileo-colonic Crohn's disease

artículo científico publicado en 2013

Comparison of two methods for the in-vivo diagnosis of Helicobacter pylori infection using a tablet of 13C-urea

artículo científico publicado en 2017

Complementary and alternative medicine in inflammatory bowel diseases: what is the future in the field of herbal medicine?

artículo científico publicado en 2014

Cross-sectional imaging modalities in Crohn's disease

artículo científico

Development of Red Flags Index for Early Referral of Adults with Symptoms and Signs Suggestive of Crohn's Disease: An IOIBD Initiative

artículo científico

Development of the Lémann index to assess digestive tract damage in patients with Crohn's disease.

artículo científico publicado en 2014

Diagnostic Delay in Crohn's Disease: Time for Red Flags

artículo científico publicado en 2016

Direct analysis in real time coupled to high resolution mass spectrometry as a rapid tool to assess salmon (Salmo salar ) freshness

scientific article published on 03 August 2018

Discontinuation of Infliximab in Patients With Ulcerative Colitis Is Associated With Increased Risk of Relapse: A Multinational Retrospective Cohort Study

artículo científico publicado en 2016

Disease patterns in late-onset ulcerative colitis: Results from the IG-IBD "AGED study".

artículo científico publicado en 2016

Dose optimization is effective in ulcerative colitis patients losing response to infliximab: a collaborative multicentre retrospective study.

artículo científico publicado en 2013

ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment

artículo científico publicado en 2020

ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment

artículo científico publicado en 2020

ECCO Position Statement on the Use of Biosimilars for Inflammatory Bowel Disease-An Update

artículo científico publicado en 2016

Editorial: evidence is growing for protective effects of 5-aminosalicylates against colitis-associated cancer-authors' reply.

artículo científico publicado en 2017

Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease-A Multicenter Retrospective European Study.

artículo científico publicado en 2018

Effectiveness of Mesalazine, Thiopurines and Tumour Necrosis Factor Antagonists in Preventing Post-Operative Crohn's Disease Recurrence in a Real-Life Setting

artículo científico publicado en 2017

Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: A prospective study*

artículo científico publicado en 2011

Efficacy of tumour necrosis factor antagonists in stricturing Crohn's disease: A tertiary center real-life experience

artículo científico publicado en 2017

Emerging biologics in the treatment of inflammatory bowel disease: what is around the corner?

scientific article published on February 2010

Emerging therapeutic targets and strategies in Crohn's disease

artículo científico publicado en 2016

Etrolizumab in ulcerative colitis: tightening leukocyte traffic control in the inflamed mucosa.

artículo científico publicado en 2014

European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies

artículo científico

European experience with methotrexate treatment in Crohn's disease: a multicenter retrospective analysis

artículo científico publicado en 2016

Familial aggregation in inflammatory bowel disease: is it genes or environment?

artículo científico publicado en 2011

Filgotinib in Crohn’s Disease: JAK Is Back

artículo científico publicado en 2017

First-line therapy in adult Crohn's disease: who should receive anti-TNF agents?

artículo científico

Full Interchangeability in Regard to Immunogenicity Between the Infliximab Reference Biologic and Biosimilars CT-P13 and SB2 in Inflammatory Bowel Disease

scientific article published on 01 February 2018

Golimumab: clinical update on its use for ulcerative colitis

artículo científico

H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biological therapy

artículo científico publicado en 2011

Health-Related Quality of Life in Italian Patients With Moderate and Severe Crohn's Disease: Interim Results from the Sole Study

article

Hyaluronan Accelerates Intestinal Mucosal Healing through Interaction with TSG-6

artículo científico publicado en 2019

IL-23 Blockade for Crohn s disease: next generation of anti-cytokine therapy

artículo científico publicado en 2017

IOIBD technical review on endoscopic indices for Crohn's disease clinical trials

artículo científico

Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn’s Disease

article

Identification of serum and tissue micro-RNA expression profiles in different stages of inflammatory bowel disease

artículo científico publicado en 2013

Improving the quality of surveillance colonoscopy in inflammatory bowel disease

scientific article published on 01 December 2019

Infliximab Therapy Inhibits Inflammation-Induced Angiogenesis in the Mucosa of Patients With Crohnʼs Disease

scientific article published on 01 March 2011

Infliximab in steroid-dependent ulcerative colitis: effectiveness and predictors of clinical and endoscopic remission

artículo científico publicado en 2013

Influenza A (H1N1)v infection in patients with inflammatory bowel disease: a case series.

artículo científico publicado en 2011

Integrins and adhesion molecules as targets to treat inflammatory bowel disease

artículo científico

Intravenous Versus Oral Iron for the Treatment of Anemia in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

artículo científico publicado en 2016

Iron deficiency: the hidden miscreant in inflammatory bowel disease.

artículo científico publicado en 2014

JAK inhibitors: Novel developments in management of ulcerative colitis

scientific article published on 01 February 2018

Janus kinase inhibitors for the treatment of inflammatory bowel diseases: developments from phase I and phase II clinical trials

artículo científico publicado en 2018

Key Strategies to Optimize Outcomes in Mild-to-Moderate Ulcerative Colitis

artículo científico publicado en 2020

Letter: immunogenicity of infliximab originator vs. CT-P13 in IBD patients

artículo científico publicado en 2017

Letter: infliximab therapy in inflammatory bowel disease patients after liver transplantation

artículo científico publicado en 2013

Leukocyte traffic control: a novel therapeutic strategy for inflammatory bowel disease

artículo científico publicado en 2010

Leukocyte traffic control: a novel therapeutic strategy for inflammatory bowel disease--an update

artículo científico

Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study.

artículo científico publicado en 2018

Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis

artículo científico publicado en 2014

MFSD2A Promotes Endothelial Generation of Inflammation-Resolving Lipid Mediators and Reduces Colitis in Mice

artículo científico publicado en 2017

MRI in Crohn's disease--current and future clinical applications

artículo científico publicado en 2011

Making a Case for Case Reports: The ECCO-CONFER Viewpoint on Investigating Rare Events in a Medical World Reigned by Group-comparative Statistics

artículo científico publicado en 2016

Mucosal healing in ulcerative colitis: where do we stand?

artículo científico publicado en 2011

Multidisciplinary management of the nocebo effect in biosimilar-treated IBD patients: Results of a workshop from the NOCE-BIO consensus group

scientific article published on 04 December 2019

Narrow-band imaging endoscopy to assess mucosal angiogenesis in inflammatory bowel disease: a pilot study

artículo científico publicado en 2010

New targeted therapies such as anti-adhesion molecules, anti-IL-12/23 and anti-Janus kinases are looking toward a more effective treatment of inflammatory bowel disease

artículo científico publicado en 2015

Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study

artículo científico publicado en 2020

PF-00547659 for the treatment of Crohn's disease and ulcerative colitis

artículo científico publicado en 2018

Paradoxical immune-mediated inflammation in inflammatory bowel disease patients receiving anti-TNF-α agents

artículo científico

Patients with Inflammatory Bowel Disease Are Not at Increased Risk of COVID-19: A Large Multinational Cohort Study

scientific article published on 31 October 2020

Perception of Reproductive Health in Women with Inflammatory Bowel Disease.

artículo científico publicado en 2016

Personalizing psychological treatment along the IBD journey: From diagnosis to surgery.

artículo científico

Positioning Therapies in Ulcerative Colitis

scientific article published on 23 January 2020

Positioning ustekinumab in moderate-to-severe ulcerative colitis: new kid on the block

scientific article published on 13 February 2020

Postoperative recurrence of Crohnʼs disease and videocapsule endoscopy: It is necessary to leave no stone unturned

scientific article published on 01 August 2008

Predicting future disease course in Crohn's disease by colonoscopy or magnetic resonance: which is the crystal ball?

artículo científico publicado en 2015

Preoperative magnetic resonance enterography in predicting findings and optimizing surgical approach in Crohn's disease

artículo científico publicado en 2013

Prevalence of Bowel Damage Assessed by Cross-Sectional Imaging in Early Crohn's Disease and its Impact on Disease Outcome.

artículo científico publicado en 2016

Preventing Collateral Damage in Crohn's Disease: The Lémann Index

artículo científico publicado en 2016

Progress with anti-tumor necrosis factor therapeutics for the treatment of inflammatory bowel disease

artículo científico publicado en 2015

Prospective comparison of computed tomography enterography and magnetic resonance enterography for assessment of disease activity and complications in ileocolonic Crohn's disease.

artículo científico publicado en 2010

Psoriasis and Inflammatory Bowel Disease: Two Sides of the Same Coin?

artículo científico publicado en 2015

Quality of care standards in inflammatory bowel diseases: a European Crohn's and Colitis Organisation (ECCO) position paper

artículo científico publicado en 2020

Regulatory T-Cell Therapy for Crohn's Disease: In Vivo Veritas

scientific article published on 20 September 2012

Research Gaps in Diet and Nutrition in Inflammatory Bowel Disease. A Topical Review by D-ECCO Working Group [Dietitians of ECCO].

artículo científico publicado en 2017

Review article: Causative factors and the clinical management of patients with Crohn's disease who lose response to anti-TNF-α therapy

artículo científico publicado en 2011

Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment

artículo científico

Review article: anti TNF-alpha induced psoriasis in patients with inflammatory bowel disease

scientific article published on 10 February 2009

Rho-A prenylation and signaling link epithelial homeostasis to intestinal inflammation

artículo científico publicado en 2016

Role of bowel ultrasound as a predictor of surgical recurrence of Crohn's disease.

artículo científico publicado en 2013

Safety and efficacy of sodium hyaluronate (IBD98E) in the induction of clinical and endoscopic remission in subjects with distal ulcerative colitis

artículo científico publicado en 2014

Second-generation corticosteroids for the treatment of Crohn's disease and ulcerative colitis: more effective and less side effects?

artículo científico

Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.

artículo científico

Sexual and reproductive issues and inflammatory bowel disease: a neglected topic in men.

artículo científico publicado en 2018

Short-term outcomes of laparoscopy combined with enhanced recovery pathway after ileocecal resection for Crohn's disease: a case-matched analysis

artículo científico publicado en 2012

State of the art: psychotherapeutic interventions targeting the psychological factors involved in IBD.

artículo científico publicado en 2014

Systematic review with meta-analysis: use of 5-aminosalicylates and risk of colorectal neoplasia in patients with inflammatory bowel disease.

artículo científico publicado en 2017

Systematic review with network meta-analysis: comparative efficacy and safety of budesonide and mesalazine (mesalamine) for Crohn's disease

artículo científico publicado en 2015

Targeting SMAD7 in Crohn’s Disease by Mongersen: Therapeutic Revolution Under Way?

artículo científico publicado en 2015

The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab Biosimilar.

artículo científico publicado en 2017

The biosimilar road in inflammatory bowel disease: the right way?

artículo científico publicado en 2014

The clinical potential of etrolizumab in ulcerative colitis: hypes and hopes

artículo científico publicado en 2016

The efficacy of shortening the dosing interval to once every six weeks in Crohn's patients losing response to maintenance dose of infliximab

artículo científico publicado en 2010

The experience with biosimilars of infliximab in inflammatory bowel disease.

artículo científico publicado en 2017

The role of magnetic resonance imaging in detecting intestinal fibrosis in Crohn's disease

artículo científico

The safety of biological pharmacotherapy for the treatment of ulcerative colitis.

artículo científico publicado en 2017

The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease

artículo científico publicado en 2015

The use of biosimilars in immune-mediated disease: A joint Italian Society of Rheumatology (SIR), Italian Society of Dermatology (SIDeMaST), and Italian Group of Inflammatory Bowel Disease (IG-IBD) position paper

artículo científico publicado en 2014

Vedolizumab for the treatment of Crohn's disease.

artículo científico publicado en 2018

Viewpoint: Knowledge and viewpoints on biosimilar monoclonal antibodies among members of the European Crohn's and Colitis Organization

artículo científico publicado en 2014

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda